Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome

Understanding the cardiovascular disease (CVD) risk for women with polycystic ovary syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the cardiometabolic profiles of different PCOS groups over a median interval of 15.8 years. The study focused on three groups: (1) wome...

Full description

Bibliographic Details
Main Authors: Kim van der Ham, Maria P. H. Koster, Birgitta K. Velthuis, Ricardo P. J. Budde, Bart C. J. M. Fauser, Joop S. E. Laven, Yvonne V. Louwers
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/16/5226
_version_ 1797584312698142720
author Kim van der Ham
Maria P. H. Koster
Birgitta K. Velthuis
Ricardo P. J. Budde
Bart C. J. M. Fauser
Joop S. E. Laven
Yvonne V. Louwers
author_facet Kim van der Ham
Maria P. H. Koster
Birgitta K. Velthuis
Ricardo P. J. Budde
Bart C. J. M. Fauser
Joop S. E. Laven
Yvonne V. Louwers
author_sort Kim van der Ham
collection DOAJ
description Understanding the cardiovascular disease (CVD) risk for women with polycystic ovary syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the cardiometabolic profiles of different PCOS groups over a median interval of 15.8 years. The study focused on three groups: (1) women with PCOS who were hyperandrogenic at both initial and follow-up screening (HA-HA), (2) those who transitioned from hyperandrogenic to normoandrogenic (HA-NA), and (3) those who remained normoandrogenic (NA-NA). At initial and follow-up screenings, both HA-HA and HA-NA groups showed higher body mass indexes compared to the NA-NA group. Additionally, at follow-up, the HA-HA and HA-NA groups exhibited higher blood pressure, a higher prevalence of hypertension, elevated serum triglycerides and insulin levels, and lower levels of HDL cholesterol compared to the NA-NA group. Even after adjusting for BMI, significant differences persisted in HDL cholesterol levels and hypertension prevalence among the groups (HA-HA: 53.8%, HA-NA: 53.1%, NA-NA: 14.3%, <i>p</i> < 0.01). However, calcium scores and the prevalence of coronary plaques on CT scans were similar across all groups. In conclusion, women with PCOS and hyperandrogenism during their reproductive years exhibited an unfavorable cardiometabolic profile during their post-reproductive years, even if they changed to a normoandrogenic status.
first_indexed 2024-03-10T23:50:05Z
format Article
id doaj.art-075085e8d7a74ecbb0df5ec00cd00622
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T23:50:05Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-075085e8d7a74ecbb0df5ec00cd006222023-11-19T01:39:58ZengMDPI AGJournal of Clinical Medicine2077-03832023-08-011216522610.3390/jcm12165226Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary SyndromeKim van der Ham0Maria P. H. Koster1Birgitta K. Velthuis2Ricardo P. J. Budde3Bart C. J. M. Fauser4Joop S. E. Laven5Yvonne V. Louwers6Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The NetherlandsDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The NetherlandsDepartment of Radiology, University Medical Center Utrecht, University of Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The NetherlandsDepartment of Radiology and Nuclear Medicine, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The NetherlandsDepartment of Reproductive Medicine & Gynecology, University Medical Center Utrecht, University of Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The NetherlandsDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The NetherlandsDivision of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Erasmus University Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The NetherlandsUnderstanding the cardiovascular disease (CVD) risk for women with polycystic ovary syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the cardiometabolic profiles of different PCOS groups over a median interval of 15.8 years. The study focused on three groups: (1) women with PCOS who were hyperandrogenic at both initial and follow-up screening (HA-HA), (2) those who transitioned from hyperandrogenic to normoandrogenic (HA-NA), and (3) those who remained normoandrogenic (NA-NA). At initial and follow-up screenings, both HA-HA and HA-NA groups showed higher body mass indexes compared to the NA-NA group. Additionally, at follow-up, the HA-HA and HA-NA groups exhibited higher blood pressure, a higher prevalence of hypertension, elevated serum triglycerides and insulin levels, and lower levels of HDL cholesterol compared to the NA-NA group. Even after adjusting for BMI, significant differences persisted in HDL cholesterol levels and hypertension prevalence among the groups (HA-HA: 53.8%, HA-NA: 53.1%, NA-NA: 14.3%, <i>p</i> < 0.01). However, calcium scores and the prevalence of coronary plaques on CT scans were similar across all groups. In conclusion, women with PCOS and hyperandrogenism during their reproductive years exhibited an unfavorable cardiometabolic profile during their post-reproductive years, even if they changed to a normoandrogenic status.https://www.mdpi.com/2077-0383/12/16/5226PCOShyperandrogenismcardiometabolic profilepost-reproductive years
spellingShingle Kim van der Ham
Maria P. H. Koster
Birgitta K. Velthuis
Ricardo P. J. Budde
Bart C. J. M. Fauser
Joop S. E. Laven
Yvonne V. Louwers
Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
Journal of Clinical Medicine
PCOS
hyperandrogenism
cardiometabolic profile
post-reproductive years
title Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
title_full Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
title_fullStr Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
title_full_unstemmed Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
title_short Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
title_sort change in androgenic status and cardiometabolic profile of middle aged women with polycystic ovary syndrome
topic PCOS
hyperandrogenism
cardiometabolic profile
post-reproductive years
url https://www.mdpi.com/2077-0383/12/16/5226
work_keys_str_mv AT kimvanderham changeinandrogenicstatusandcardiometabolicprofileofmiddleagedwomenwithpolycysticovarysyndrome
AT mariaphkoster changeinandrogenicstatusandcardiometabolicprofileofmiddleagedwomenwithpolycysticovarysyndrome
AT birgittakvelthuis changeinandrogenicstatusandcardiometabolicprofileofmiddleagedwomenwithpolycysticovarysyndrome
AT ricardopjbudde changeinandrogenicstatusandcardiometabolicprofileofmiddleagedwomenwithpolycysticovarysyndrome
AT bartcjmfauser changeinandrogenicstatusandcardiometabolicprofileofmiddleagedwomenwithpolycysticovarysyndrome
AT joopselaven changeinandrogenicstatusandcardiometabolicprofileofmiddleagedwomenwithpolycysticovarysyndrome
AT yvonnevlouwers changeinandrogenicstatusandcardiometabolicprofileofmiddleagedwomenwithpolycysticovarysyndrome